Here's Won't Touch Teva: Why I Pass on the Generic Giant
Teva Pharmaceuticals sits at a crossroads of debt, generics, and a shifting pricing landscape. Here's why I won't tou...
Evaluate how withdrawal strategies affect taxes when holding Total Market and Total World retirement assets.
28,525 articlesTeva Pharmaceuticals sits at a crossroads of debt, generics, and a shifting pricing landscape. Here's why I won't tou...
Grab is accelerating its push into physical AI and automated driving, testing robots in Singapore and at its own offi...
When a high-profile investor makes a big move, questions follow. This guide cuts through the headlines to examine Ali...
BigBear.ai has emerged as a key name in enterprise AI and decision intelligence. This guide breaks down bigbear.ai (b...
A mobile app that pays users for scrolling is surging in adoption, propelling a small software firm into what analyst...
Pricing swings often follow earnings news. This guide breaks down whether to buy NOW stock before July 22, with pract...
Analysts warn that a move to $100 oil would erode Delta and United's 2026 earnings guidance, likely pushing shares lo...
Vistra's Q1 2026 results shed light on margin dynamics across generation, retail, and renewables. This guide breaks d...
A major strategic move lands in Voyager Technologies’ lap as it closes the Astrobotic acquisition while securing a he...
A legendary investor makes a bold AI move. He recently closed a position in a company famous for aggressive AI spend ...
Silicon Valley is fueling a defense tech surge, reshaping the investment landscape. This piece identifies five stocks...
When a growth stock down nearly 50% from its high looks tempting, it helps to separate hype from fundamentals. This g...